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As discussed in the larger review in this special issue (MacDonald and Feifel), intranasal
oxytocin (OT) is demonstrating a growing potential as a therapeutic agent in psychiatry.
Importantly, research suggests that a variety of individual factors may influence a person’s
response to OT. In this mini-review, I provide a review of three: (1) sex and hormonal status;
(2) genetic variation in aspects of the OT system (i.e., OT receptors); and (3) attachment
history. Each of these factors will be important to monitor as we strive to develop a richer
understanding of OT’s role in human development, brain-based disease, and the potential
for individualized, OT-targeted treatments.
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INTRODUCTION
Aside from a wide range of drug-specific factors (discussed in
MacDonald and Feifel in this special edition), several individual
factors may influence a person’s response to oxytocin. Three of
these factors are reviewed below.
SEX AND HORMONAL STATUS
The central OT system acts as but one component of a complex
neurochemical milieu in which gonadal steroids also play a signif-
icant part. As extensively discussed in recent full-length reviews,
gonadal steroid hormones (i.e., estrogen, progesterone, and testos-
terone), and the two nonapeptides – OT and arginine vasopressin
(AVP) – coevolved, all playing a vital role in mammalian social
development through their unique influence on parental bond-
ing, mate choice, and attachment (van Anders et al., 2011; Bos
et al., 2012). In toto, there is substantial evidence indicating that
at least some of oxytocin’s effects are correlated with an individ-
ual’s sex, in part via the influence of gonadal hormones. We can
only give this important topic brief review, and direct the reader
to more comprehensive treatments (van Anders et al., 2011; Bos
et al., 2012; Gabor et al., 2012).
As background, animal studies indicate that sex-specific dif-
ferences in response to OT are common (Williams et al., 1994;
Cho et al., 1999; Bales and Carter, 2003; Bales et al., 2007), and
the histological structure for OT neurons is sexually dimorphic,
suggesting that sex steroids play a role in early morphogenesis
of this system (de Vries, 2008). Estrogen upregulates OT and
OT receptor (OTR) production (Patisaul et al., 2003; Windle
et al., 2006; Choleris et al., 2008), whereas testosterone promotes
both OTR binding in the hypothalamus (Johnson et al., 1991)
as well as production of AVP (Delville et al., 1996), which has
many opponent actions to OT (Neumann and Landgraf, 2012).
In humans, moreover, testosterone seems from one perspective
to have opposite behavioral effects to the prosocial impact clas-
sically associated with OT: decreasing trust, generosity, empathy
(van Honk and Schutter, 2007; Zak et al., 2009; Bos et al., 2010),
though more recent conceptualizations of the parochial, “us vs.
them” aspect of OT make this picture more complex, and evi-
dence OT’s “darker” side (Shamay-Tsoory et al., 2009; De Dreu
et al., 2010, 2011, 2012; Declerck et al., 2010). Though OT is only
one small piece of the complex psychobiology of gender, some have
posited different OT-biased relational strategies for the sexes, with
females more prone to“tend and befriend”(Taylor et al., 2000; but,
see Smith et al., 2012b), whereas more warrior-prone, hierarchy-
bound males “compete and defeat” (David and Lyons-Ruth, 2005;
Smeets et al., 2009; Van Vugt, 2009; Gabor et al., 2012).
More evidence for sex-specific differences in the OT system
come from research indicating that men and women show dif-
ferences in plasma OT levels (Ozsoy et al., 2009; Gordon et al.,
2010; Holt-Lunstad et al., 2011; Weisman et al., 2012b), as well
as gender-specific behavioral correlations with OT (Gordon et al.,
2010; Zhong et al., 2012; but, see Szeto et al., 2011 for critique
of plasma OT measurement techniques). Coming from the per-
spective of genetic variations in nonapeptide receptors, Walum
et al. (2012) have found an association between the OTR vari-
ant rs7632287 and pair-bonding behaviors in women but not
in men, whereas an earlier study found an association of an
AVP receptor polymorphism and pair-bonding in men but not
women (Walum et al., 2008). Furthermore, numerous studies in
the growing OTR literature note sex-specific associations between
genetic variants in the OTR gene and personality characteristics
(Stankova et al., 2012), neural responses to emotionally salient
cues (Tost et al., 2010), hypothalamic gray matter volume (Tost
et al., 2010), and empathy (Wu et al., 2012), though other studies
in this area have failed to find a sex bias (Rodrigues et al., 2009;
Saphire-Bernstein et al., 2011; Feldman et al., 2012). A final set
of salient investigations found that amygdala-prefrontal cortical
connectivity – which can be impacted by OT in normal sub-
jects (Sripada et al., 2012) and anxiety patients (Labuschagne
et al., 2011) – may be related in a gender-specific way to
the development of anxiety and depressive disorders (Burghy
et al., 2012), both putative clinical targets for intranasal oxytocin
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(IN OT) (Slattery and Neumann, 2010; Neumann and Landgraf,
2012).
Focusing on clinical OT trials using IN OT, gender-dependent
effects have been demonstrated in some single-dose studies
(Hurlemann et al., 2010), including studies of effects on they amyg-
dala (Domes et al., 2010; Rupp et al., 2012), and interpersonal
behavior (Liu et al., 2012) but – consistent with the variability in
this literature – many other single-dose studies have not found an
effect of sex (see Bartz et al., 2011b for review). A recently investi-
gated individual factor at least partly related to sex (due to different
sexual selection strategies between males and females; Ihara and
Aoki, 1999) is the relationship status of the person receiving the
drug. Specifically, Scheele et al. (2012) found in a group of 86 nor-
mal heterosexual males that IN OT preferentially stimulated men
in a monogamous relationship – but not single males – to main-
tain more personal space from women (but not men). Whether
these effect would cross over to females and same-sex relationships
in interesting and unexplored.
Though the suggestion of gender effects in single-dose studies
of normal subjects may be informative, as discussed in the accom-
panying larger review (MacDonald and Feifel), these results do not
speak directly to the clinical question of whether sex differences
moderate the effects of chronic OT treatment in clinically ill pop-
ulations. The first study to intimate such a sex moderation effect
was a randomized, double-blind, within-subjects crossover study
of OT (40 IU BID for 3 weeks) in patients with generalized anxi-
ety disorder (GAD) (Feifel et al., 2011). This trial demonstrated a
trend level dose-by-gender effect such that males treated with OT
showed a significant clinical improvement in HAM-A scores with
OT, whereas females showed higher HAM-A scores during 3 weeks
of treatment. The three extant studies using multiple weeks of OT
treatment in patients with schizophrenia demonstrated a male
bias in recruitment (62 males treated vs. 13 females), though none
showed a sex-by-drug effect (Feifel et al., 2010; Pedersen et al.,
2011; Modabbernia et al., 2012). Notable in this context are studies
by Rubin et al. (2010, 2011) indicating that female but not male
patients with schizophrenia show a correlation between plasma
OT concentrations, perception of facial emotion expression, and
psychopathology, as well as evidence that women with borderline
personality disorder have reduced plasma OT levels, even after
controlling for hormonal factors (Bertsch et al., 2012).
In terms of future clinical studies with IN OT, the abovemen-
tioned sex-specific variables may have at least two repercussions.
First, they highlight the importance of monitoring/measuring hor-
mone levels,menstrual phase,and oral contraceptive status in trials
with IN OT, given these parameters may impact OT levels (Salonia
et al., 2005, but, see Rubin et al., 2011) and psychiatric symptoms
(Rubin et al., 2010). Secondly, given that there are sex differences
in the incidence of many of the disease states for which OT is a
putative treatment (i.e., autism, postpartum depression), further
delineation of the role of sex in the effects of chronic OT treatment
will be critical.
NEUROPEPTIDERGIC INDIVIDUALITY: GENETIC VARIATIONS
IN OTR AND CD38
Aside from sex, a second individual factor of import in relation
to IN OT treatment involves phenotypically relevant individual
genetic variations within different aspects of the OT system (Kum-
sta and Heinrichs, 2012), what one could call “neuropeptidergic
individuality.” This term is annexed from – and a subset of – what
Cravchik has called “neurochemical individuality”: genetically
determined factors that underlie individual differences in brain
function. Exemplars include variations in aspects of the major
neurotransmitter systems (i.e., dopamine, serotonin) (Cravchik
and Goldman, 2000).
In terms of OTs part in “neuropeptidergic individuality,” a
recent, rapidly expanding body of literature indicates that genetic
differences in aspects of the functional OT system (the OTR itself
and the ectoenzyme CD38, which contributes to OT secretion)
(Figure 1) contribute to measurable aspects of an individual’s
personality (Kumsta and Heinrichs, 2012). Though the specific
cellular and functional consequences of these genetic variations
have not been fully explicated, a convergent picture of their phe-
notypic consequences is emerging, indicating that in neurotypical
subjects, genetic differences in the OT system impacts positive
personality factors and social behavior (Bakermans-Kranenburg
and van Ijzendoorn, 2008; Rodrigues et al., 2009; Montag et al.,
2011; Saphire-Bernstein et al., 2011; Walter et al., 2012), differen-
tial responses to stress and maltreatment (Kim et al., 2010; Bradley
et al., 2011; Chen et al., 2011b; Thompson et al., 2011; Brune, 2012;
Norman et al., 2012), brain anatomy (Inoue et al., 2010; Furman
et al., 2011), and differences in the function of stress and emotion-
related brain areas (Tost et al., 2010; Love et al., 2012). Moreover,
genetic variation in the OT system has been implicated in several
of the disease states where OT has shown the most therapeutic
promise: schizophrenia (Teltsh et al., 2011; Montag et al., 2012)
and autism (Ebstein et al., 2012).
Though no published studies have examined the role of genetic
variation in the OT system to a psychiatrically ill person’s clinical
response to OT, several recent studies in normal subjects indicate
that we should be alert for such effects. For example: subjective
responses to infant’s faces were moderated by the (rs53576G)
allele of the OTR (Marsh et al., 2012); there is an association
between several genetic variations in the OTR (rs53576, rs2254298,
rs2228485) and performance on the Reading the Mind in the Eyes
Test (RMET) (Lucht et al., 2012); and the OXTR (rs2268498)
polymorphism modulated neural responses to emotional faces
(O’Connell et al., 2012). Moreover, as evidence of the overlap
between central dopaminergic and oxytocinergic systems, female
OTR (rs4813625) carriers demonstrated greater stress-induced
dopamine release, higher attachment and trait anxiety, and lower
emotional well-being scores (Love et al., 2012).
A relatively new component of the central OT system – but
one which is rapidly galvanizing interest – is the transmembrane
enzyme CD38, whose role was discovered by observing the social
behavior of CD38 knock-out mice. These socially hapless mice
forget the location of their pups as well as previous social encoun-
ters, and synthesize, but don’t properly secrete OT. Notably, these
behavioral and hormonal deficits are restored with either (a) viral
transfection of a functional CD38 gene or (b) exogenous OT (Jin
et al.,2007). In humans,variants in the CD38 gene have been tied to
OT secretion (Kiss et al., 2011), social processing (Higashida et al.,
2012a; Sauer et al., 2012), sensitive parenting (Feldman, 2012),
and potentially autism (Higashida et al., 2011, 2012b for review).
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FIGURE 1 |Three individual factors which mediate response to oxytocin
are (1) sex and hormonal status; (2) genetic variations in the oxytocin
receptor and CD38 system; and (3) early attachment experiences. The
extent to which these factors play a role in a person’s response to
oxytocin-targetted therapeutics for brain-based disease requires further
exploration (see MacDonald and Feifel in this special section).
Similarly to the OTR studies above, a recent imaging genetics study
in neurotypical males suggested that variation in the CD38 gene
influenced behavioral and neuronal measures of social processing
and amygdala response to IN OT (Sauer et al., 2012). A clinical
point of interest in this context is that retinoids (vitamin-A related
compounds) can be used to increase CD38 expression (Riebold
et al., 2011), thus providing an alternative way to stimulate the OT
system or potentially augment IN OT treatment (Ebstein et al.,
2011).
Though the focus here is only on variation in the OTR and
CD38 gene, other potential contributors to neuropeptidergic indi-
viduality include: (1) differences in baseline and dynamic levels of
OT release in the brain and/or secretion into the plasma, the latter
found to correlate with personality and brain structure (Andari
et al., 2012); as well as (2) differences in regional OTR and AVPR
receptor density, a factor which influences the social behavior of
rodents (Hammock and Young, 2006; Ross et al., 2009; Ophir et al.,
2012). Though a few studies have examined postmortem OTR
density in the human CNS (Loup et al., 1989, 1991), as mentioned
in the accompanying review (MacDonald and Feifel), synthesis of
a small-molecule radioligand for the OTR (Smith et al., 2012a),
would greatly facilitate our understanding of the role of OTR
density and location in living humans.
Of critical import in the field of psychiatric genetic association
studies are the issues of replicability and effect size (discussed at
length in Gershon et al., 2011; Ebstein et al., 2012). For example, in
contrast to several of the positive associations noted above, studies
have failed to find associations between genetic variations in the
OTR and prosocial behavior in the trust or dictator game (Apicella
et al., 2010), optimism (Cornelis et al., 2012), and autism (Tansey
et al., 2010). Replication studies and larger sample sizes in a vari-
ety of populations using different varieties of associations (i.e.,
different combinations of haplotypes) (Yamasue et al., 2012) are
therefore necessary to more fully explore and quantify the strength
of the abovementioned associations.
Returning to the clinical implications of neuropeptidergic indi-
viduality, it is possible that individual variation in aspects of
the OT system may in the future be thought of as clinicians
currently conceptualize individual variations in dopamine and
serotonin systems. One brings to mind the association of DRD4
variants with approach-related traits (Munafo et al., 2008) and
response to dopaminergic medication (Hamarman et al., 2004),
or the association of serotonin receptor polymorphisms with sus-
ceptibility to adverse clinical outcomes (van Ijzendoorn et al.,
2012), as well as response to serotonergic antidepressants (Mrazek
et al., 2009). Aside from its import in terms of understanding
individual variability in both neurotypical and clinically ill pop-
ulations, neuropeptidergic individuality may have implications in
terms of psychiatric pharmacogenetics: the use of information
about individual’s genotype in the selection of psychiatric treat-
ment (Malhotra et al., 2007). Though this approach is currently
speculative in terms of OT, it has growing clinically relevance
for antidepressants (McMahon et al., 2006) and antipsychotics
(Zhang et al., 2010). Looking forward, large clinical trials are
needed to investigate the possibility that genetic variations in the
abovementioned aspects of the OT system may influence clini-
cal response to OT treatment. That said, the decreasing cost and
increasing efficiency of gene sequencing technologies, coupled
with larger clinical trials of clinical use of OT (ClinicalTrials.gov),
will certainly inform the relevance of this proposed genotype-
informed treatment. Moreover, identification of “OT sensitive”
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phenotypes may optimize patient selection for treatment and
trials.
EARLY EXPERIENCE, EPIGENETICS, AND NEUROPLASTICITY
In addition to abovementioned genetically determined factors, a
third influence on a person’s response to IN OT concerns the way
that that an individual’s unique attachment history has sculpted
the function of their OT system (Gordon et al., 2011; Bales and
Perkeybile, 2012). More specifically, convergent translational and
developmental research in a variety of fields indicates that the
central OT system is similar to the HPA axis in being an environ-
mentally influenced plastic brain system whose function is directly
and perhaps permanently impacted by early experience (Gunnar
and Quevedo, 2008; Brune, 2012; McCrory et al., 2012). Clinically,
it is clear that maladaptive early experiences impact the “pheno-
type” of several psychiatric disorders that may benefit from IN OT,
including depression (Saveanu and Nemeroff, 2012) and schizo-
phrenia (Read and Hammersley, 2005; van Os et al., 2010). Recent
imaging studies indicate that early adversity impacts brain sys-
tems of import to both psychiatric disease and OT treatment (i.e.,
amygdala and hippocampus; Dannlowski et al., 2012; Teicher et al.,
2012).
Research on the environmental plasticity of the OT system
began with sentinel animal research indicating intergenerational
transmission of behavior in more- and less-attentive rat moth-
ers (Champagne and Meaney, 2001; Champagne et al., 2001;
Meaney, 2001). Some of these changes, notably, are mediated via
epigenetic modulation of the OT system (Cushing and Kramer,
2005; Stolzenberg et al., 2012). More recently, human experi-
ments support the hypothesis that dynamic changes in com-
ponents of the OT system (i.e., methylation of the OTR gene;
Jack et al., 2012; Unternaehrer et al., 2012) and possibly neu-
rodevelopmental changes in OT sensitive brain structures (see
Andari et al., 2012 for discussion) are some of the proximate
effectors through which early parental care impacts an individ-
ual throughout life (Champagne et al., 2001; Champagne, 2008;
Gordon et al., 2011; Bales and Perkeybile, 2012 for reviews). Other
convergent evidence comes from attachment-informed behavioral
research which indicates parallels and reciprocal influence between
parental and infant OT levels and the species-specific behav-
iors associated with secure attachment and optimal psychosocial
development (Feldman, 2012). As mentioned above, these fac-
tors appear to be influenced by both genetic variations in the OT
system and by IN OT (Naber et al., 2010, 2012; Weisman et al.,
2012a).
Focusing specifically on the OT treatment literature, several
studies indicate that aversive early attachment experiences and
attachment style impact stress systems, CSF, and plasma OT levels
(Heim et al., 2009; Strathearn et al., 2009, 2012; Bertsch et al., 2012;
Weisman et al., 2012a) as well as later response to IN OT (Huffmei-
jer et al., 2011, 2012; Simeon et al., 2011; van Ijzendoorn et al.,
2011; Bakermans-Kranenburg et al., 2012; Pierrehumbert et al.,
2012). For example, neurotypical patients’ generosity in response
to IN OT is moderated by parental love-withdrawal (Huffmeijer
et al., 2012), and patients with aversive early attachment repre-
sentations had a negative response to IN OT compared to those
with more positive representations (Bartz et al., 2010). Other lit-
erature suggests that variation in the OT system may mediate
gene-environment interactions between early adversity and out-
comes (Kim et al., 2010; Bradley et al., 2011; Chen et al., 2011a;
Thompson et al., 2011).
In toto, data reviewed here support the hypothesis that an
individual’s early attachment experiences – carried forward in
OT-responsive neural networks and the dynamic function of the
central OT system – may impact a person’s response to IN OT. To
date, in keeping with the general trend noted throughout this and
the accompanying larger review (MacDonald and Feifel, this issue)
the evidence that early experience impacts OT response in clini-
cal populations is sparse. The only published study in this area
demonstrated that patients with borderline personality disorder
and anxious attachment showed less trust than those with more
secure attachment after IN OT (Bartz et al., 2011a). Despite the
overall lack of studies of IN OT in patient groups, the findings
cited above suggest that clinical trials examining putative ther-
apeutic effects of OT will be wise to include an assessment of
attachment style and early trauma as individual factors that may
influence response to OT.
CONCLUSION
Given the paucity of clinical trials with IN OT, the suggestion that
the above factors may be moderators of clinical response to IN
OT should be viewed with circumspection. Both larger-scale ther-
apeutic trials with IN OT as well as investigations of the role of
aspects of the central OT system in different disease states will
be necessary to determine their ultimate clinical and therapeutic
relevance.
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